Natco Pharma Ltd has announced successful completion of inspection by USFDA of its formulations plant at Kothur in Telangana. The US Food and Drug Administration has sent the Establishment Inspection Report (EIR) for the inspection conducted at the facility during May 30–June 5, it said in a release.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.